FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Federal Register

Draft Guides on ANDA Bioequivalence Studies

Federal Register notice: FDA makes available additional draft and revised draft product-specific guidances on, among other things, the design of bioeq...

Medical Devices

FDA Warns Unapproved Thermography Device Maker

FDA issues a Warning Letter to Total Thermal Imaging for illegally marketing and distributing an unapproved thermography device as a sole screening de...

Federal Register

Guide on Implanted Brain-Computer Interface Device

Federal Register notice: FDA makes available a draft guidance entitled Implanted Brain-Computer Interface Devices for Patients with Paralysis or Amput...

Federal Register

Comments Extended on IRB Proposed Rule

Federal Register notice: FDA reopens the comment period for an 11/15/2018 proposed rule on Institutional Review Board Waiver or Alteration of Informed...

Medical Devices

FDA Clears Alphatecs Neuromonitoring System

FDA clears an Alphatec Holdings 510(k) for the SafeOp neuromonitoring system for use in real-time intraoperative nerve location and health assessments...

Human Drugs

2 Guides on Clin Pharm and Bioavailability

FDA posts two draft guidances to help drug developers with food effect studies and bioavailability studies.

Human Drugs

Taiho Oncology NDA Approved for Lonsurf

FDA approves a Taiho Oncology NDA for Lonsurf (trifluridine and tipiracil) for treating adult patients with metastatic gastric or gastroesophageal jun...

Medical Devices

Spirosure Fenom Pro Asthma Monitor Cleared

FDA clears a Spirosure 510(k) for its Fenom Pro Asthma Monitor for use by allergists, immunologists and pulmonologists to help patients manage asthma ...

Human Drugs

Macleods Pharm Recalls 1 Lot of Hypertension Drug

Macleods Pharmaceuticals recalls one lot of losartan potassium/hydrochlorothiazide 100mg/25mg combination tablets due to an impurity level concern.

Human Drugs

Safety Alert on Pfizers Xeljanz

A new FDA safety alert warns about Pfizers tofacitinib (Xeljanz, Xeljanz XR) after a clinical trial found an increased risk of blood clots in the lung...